BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12894885)

  • 1. Liver transplantation in patients with fulminant hepatitis B: experience in Canton, China.
    Zhu X; Chen G; He X; Lu M; Wang G; Cai C; Yang Y; Huang J
    Chin Med Sci J; 2002 Mar; 17(1):44-6. PubMed ID: 12894885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and treatment of hepatitis B relapse after liver transplantation.
    Zhu X; Lu M; Wang G; Cai C; Yang Y; He X; Chen G; Huang J
    Chin Med J (Engl); 2001 Jan; 114(1):73-5. PubMed ID: 11779441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation.
    Chan HL; Chui AK; Lau WY; Chan FK; Wong ML; Tse CH; Rao AR; Wong J; Sung JJ
    J Med Virol; 2002 Oct; 68(2):182-7. PubMed ID: 12210406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fulminant and subfulminant hepatitis treated by orthotopic transplantation of the liver. Apropos of 10 cases].
    Pouyet M; Ducerf C; Gaussorgues P; Salord F; Sirodot M; Caillon P; Dubois JM; Rivoire M; Baulieux J; Bouletreau P
    Chirurgie; 1989; 115(8):533-9. PubMed ID: 2700160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of hepatitis B recurrence after liver transplantation using lamivudine and hepatitis B immune globulin.
    Ołdakowska-Jedynak U; Paczek L; Foroncewicz B; Mucha K; Nyckowski P; Zieniewicz K; Ziarkiewicz-Wróblewska B; Ziółkowski J; Pilecki T; Patkowski W; Górnicka B; Paczkowska A; Krawczyk M
    Ann Transplant; 2007; 12(3):28-32. PubMed ID: 18290567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver transplantation at the Sun Yat-Sen University of Medical Sciences in China.
    Huang J; He X; Chen G; Zhu X; Lu M; Wang G; Fu Y; Yang Y; Guan X
    Chin Med J (Engl); 2002 Apr; 115(4):543-8. PubMed ID: 12133294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation.
    Seehofer D; Rayes N; Steinmüller T; Müller AR; Settmacher U; Neuhaus R; Radke C; Berg T; Hopf U; Neuhaus P
    Liver Transpl; 2001 Nov; 7(11):976-82. PubMed ID: 11699034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience.
    Tillmann HL; Hadem J; Leifeld L; Zachou K; Canbay A; Eisenbach C; Graziadei I; Encke J; Schmidt H; Vogel W; Schneider A; Spengler U; Gerken G; Dalekos GN; Wedemeyer H; Manns MP
    J Viral Hepat; 2006 Apr; 13(4):256-63. PubMed ID: 16611192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of subacute hepatitis B with lamivudine: a pilot study in Serbia.
    Delić D; Nesić Z; Prostran M; Boricić I; Svirtlih N
    Vojnosanit Pregl; 2009 Mar; 66(3):199-202. PubMed ID: 19341224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients.
    Lee WC; Wu MJ; Cheng CH; Chen CH; Shu KH; Lian JD
    Am J Kidney Dis; 2001 Nov; 38(5):1074-81. PubMed ID: 11684562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Auxiliary partial orthotopic liver transplantation for fulminant hepatitis. The Paul Brousse experience.
    Bismuth H; Azoulay D; Samuel D; Reynes M; Grimon G; Majno P; Castaing D
    Ann Surg; 1996 Dec; 224(6):712-24; discussion 724-6. PubMed ID: 8968226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamivudine prophylaxis in liver transplantation for hepatitis B in Asians.
    Lo CM; Fan ST; Lai CL; Liu CL; Yuen MF; Ng IO; Wong J
    Transplant Proc; 1999; 31(1-2):535-6. PubMed ID: 10083224
    [No Abstract]   [Full Text] [Related]  

  • 13. Additional benefit of lamivudine treatment as a preventive therapy for hepatic encephalopathy in patients with decompensated liver cirrhosis associated with hepatitis B.
    Hanada S; Kumashiro R; Kaji R; Harada M; Sata M
    Int J Mol Med; 2002 Nov; 10(5):647-8. PubMed ID: 12373309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylaxis of recurrent hepatitis B in Chinese patients after liver transplantation using lamivudine combined with hepatitis B immune globulin according to the titer of antibody to hepatitis B surface antigen.
    Jiao ZY; Jiao Z
    Transplant Proc; 2007 Jun; 39(5):1533-6. PubMed ID: 17580182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation.
    Bartholomew MM; Jansen RW; Jeffers LJ; Reddy KR; Johnson LC; Bunzendahl H; Condreay LD; Tzakis AG; Schiff ER; Brown NA
    Lancet; 1997 Jan; 349(9044):20-2. PubMed ID: 8988118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation.
    Ben-Ari Z; Mor E; Shapira Z; Tur-Kaspa R
    Liver Transpl; 2001 Feb; 7(2):113-7. PubMed ID: 11172394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylaxis of hepatitis B recurrence in post-liver transplantation patients with lamivudine-resistant YMDD mutant.
    Yang Y; Zhang Q; Cai CJ; Lu MQ; Li X; Jiang N; Jiang H; Xu C; Li H; Wang GS; Yi SH; Zhang J; Zhang JF; Yi HM; Zhang YC; Chen GH
    Chin Med J (Engl); 2007 Aug; 120(16):1400-3. PubMed ID: 17825167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on the efficacy and safety of adefovir dipivoxil treatment in post-liver transplant patients with hepatitis B virus infection and lamivudine-resistant hepatitis B virus.
    Bárcena R; Del Campo S; Moraleda G; Casanovas T; Prieto M; Buti M; Moreno JM; Cuervas V; Fraga E; De la Mata M; Otero A; Delgado M; Loinaz C; Barrios C; Dieguez ML; Mas A; Sousa JM; Herrero JI; Muñoz R; Avilés JF; Gonzalez A; Rueda M
    Transplant Proc; 2005 Nov; 37(9):3960-2. PubMed ID: 16386596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Orthotopic liver transplantation: report of 70 cases].
    Chen G; He X; Zhu X
    Zhonghua Wai Ke Za Zhi; 2001 Sep; 39(9):679-83. PubMed ID: 11769601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation.
    Ferretti G; Merli M; Ginanni Corradini S; Callejon V; Tanzilli P; Masini A; Ferretti S; Iappelli M; Rossi M; Rivanera D; Lilli D; Mancini C; Attili A; Berloco P
    Transplant Proc; 2004 Apr; 36(3):535-8. PubMed ID: 15110584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.